ArticleOncogene2022

IL-36 signalling enhances a pro-tumorigenic phenotype in colon cancer cells with cancer cell growth restricted by administration of the IL-36R antagonist.

Kevin Baker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.